Causal Inference for All: Marginal Estimands for Outcomes Truncated by Death

summary

The gist

In longitudinal studies, outcomes are often truncated by death, meaning that they are only observed or well-defined conditional on intercurrent events such as survival <ref:2607.00222#pg2> The…

In short

The paper develops new causal methods for outcomes truncated by death to characterize individual potential outcome trajectories across two survival periods: guaranteed and extended survival. It introduces three classes of estimands—while guaranteed-survival, while extended-survival, and single-world marginal separable effects—and provides identification and estimation techniques using substitution variables.

Key concepts

Guaranteed Survival Period
This is the time interval during which an individual is expected to be alive under both potential treatments. It defines the baseline survival window where both treatment paths are fully observable, making it useful for summarizing effects over that initial period.
Extended Survival Period
This refers to the additional survival time that one treatment might prolong compared to another. This estimand focuses specifically on the extra duration an individual survives under a particular intervention, rather than just the total survival time.
Marginal Separable Effects
This class of estimands compares interventions by varying an outcome-related component (ZY) while keeping a survival-related component (ZS) fixed. This generalizes previous work to the full population and allows researchers to isolate the effect of one factor independent of others.

Terminology used across episodes

This episode discusses

The paper

Causal Inference for All: Marginal Estimands for Outcomes Truncated by Death · Read on arXiv

Ruixuan Zhao, Mats Stensrud, Linbo Wang

Department of Computer and Mathematical Sciences, University of Toronto Scarborough · Institute of Mathematics, Ecole Polytechnique Fédérale de Lausanne · Department of Statistical Sciences, University of Toronto

Transcript

Introduction to the show: ident: Statistics. The day in statistics: methods, theory and the inference under them.

Tom: We're looking at the paper: "Causal Inference for All".

Jane: Here's the gist of the paper. In longitudinal studies, outcomes are often truncated by death, meaning that they are only observed or well-defined conditional on intercurrent events such as survival <ref:2607.00222#pg2> The authors introduce methodology for a new set of estimands that (i) concern the entire population, (ii) remain causally interpretable, and (iii) leverage the longitudinal data commonly available in studies with outcomes truncated by death <ref:2607.00222#pg4>.

Tom: Defining New Estimands The paper introduces a set of estimands that characterize the potential outcome trajectories of each individual across two distinct survival periods: the guaranteed survival period and the extended survival period <ref:2607.00222#pg10>.

Jane: The guaranteed survival period, 0 ≤ t ≤ Ti(1) ∧ Ti(0), is defined as the period during which the individual would be alive under both treatments.

Tom: The extended survival period, Ti(1) ∧ T(0) < t ≤ Ti(1) ∨ T(0), is the additional survival time under the treatment that would prolong survival.

Paper summary: Tom: We started by looking at why these truncations are a problem. The paper points out that outcomes in longitudinal studies are often only well-defined conditional on survival, and this restriction creates a fundamental challenge for causal inference because contrasts restricted to those who survive don't necessarily have a causal interpretation.

Jane: So, the core thesis is that existing strategies have a trade-off: you can get causally interpretable estimands that target a specific subgroup of survivors, or you can use while-alive and composite summaries that apply to the whole population but are hard to interpret as true causal effects on non-mortality outcomes.

Lu: The authors address this by introducing methodology for a new set of estimands specifically designed to concern the entire population, remain causally interpretable, and leverage the longitudinal data we often have when outcomes are truncated by death.

Meng: They introduce these new estimands that characterize individual outcome trajectories across two distinct survival periods: the guaranteed survival period and an extended survival period under a treatment.

Lalam: The guaranteed survival period is defined as the time from zero up to Ti one and Ti zero, which is the time an individual would be alive under both treatments.

Tom: Then there's the extended survival period, which is defined as that additional survival time under the treatment that would prolong someone's life beyond what they'd survive otherwise.

Jane: They then classify these into three main groups: 'while guaranteed-survival' estimands, 'while extended-survival' estimands focusing on that extra survival time, and single-world marginal separable effects.

Lu: The while guaranteed-survival estimands summarize treatment effects over the period from zero up to Ti one and Ti zero, aiming to keep the full population appeal of while alive and composite summaries.

Meng: And then there are the while extended-survival estimands which focus specifically on that additional survival time under the treatment that extends life.

Lalam: Finally, they have single-world marginal separable effects which generalize conditional separable effects to cover the full population by comparing interventions that vary an outcome component while holding a survival component fixed.

Tom: Their identification and estimation results are developed using a substitution-variable approach for those first two classes, and an influence function-based estimator for the marginal separable ones under specific treatment decompositions.

Jane: For identification of those marginal separable effects, they achieve it by solving a system of four equations that come from the observed distribution.

Lu: And when they apply this methodology to a reanalysis of a prostate cancer trial, they found that the estimated benefit of one treatment compared to another depends on the clinical goal you are interested in.

Meng: That’s a key finding because it shows that DE appears more favorable when you emphasize exit-time or end-of-life outcomes, which is useful for setting realistic expectations.

Conclusion: Tom: So, to wrap up 'Causal Inference for All: Marginal Estimands for Outcomes Truncated by Death', the paper provides a new way to estimate causal effects in these tricky longitudinal settings by focusing on whole-population estimands that are interpretable.

Jane: The authors introduce these three classes of estimands—guaranteed survival, extended survival, and marginal separable effects—to bridge the gap between survivor-restricted estimates and full-population summaries.

Lu: It’s about making sure that even when you only have data while someone is alive, you can still get causal conclusions that apply to everyone.

Meng: The implication for deployment is that we might be able to use these tools to make decisions in clinical settings where survival truncation is a major factor, provided the specific assumptions about monotonicity hold true for the data.

Lalam: Ultimately, this work gives us concrete formulas—like those derived in Section four point three—for estimating these new estimands using maximum likelihood estimators, which are triply robust under certain constraints.

Tom: It’s a lot of technical machinery, but the paper shows that the method is sound for addressing the challenge of survival truncation by providing interpretable ways to look at longitudinal data.

Jane: So, it moves us toward a framework where we can handle these real-world longitudinal datasets without immediately having to restrict our conclusions only to those who happen to survive.

More episodes

← Home